Loading stock data…
DH
$0.85+0.00 (+0.47%)
Market ClosedLast close Jun 9
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Definitive Healthcare Corp. in the Healthcare sector is trading at $0.85 with a market capitalization of $93M. Wall Street consensus targets $2.46 (7 analysts), implying a +189.7% move over the next 12 months. The stock is currently near its 52-week low of $0.80, remaining 61.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +189.7% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$0.85
Potential Downside
0%
Whystock Fair Value$0.85
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers an...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$92.63M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.34
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-116.47%
Volume
Today's trading volume
192,155
Recent News
Innoviz Technologies Among 3 Compelling Penny Stocks To Consider
The United States market has shown positive momentum recently, climbing 1.6% over the past week and 28% over the last year, with expectations of continued earnings growth. While the term "penny stock" may evoke images of speculative trading from a bygone era, these stocks can still present valuable opportunities when backed by strong financials and potential for growth. This article explores several penny stocks that stand out for their financial resilience and potential to offer investors...
Can Definitive Healthcare Corp. (DH) Maintain Stability After Revised Price Target From Baird?
We recently compiled a list of the 10 Best Penny Stocks Under $1 According to Hedge Funds. Definitive Healthcare Corp. (NASDAQ:DH) is among the best penny stocks on this list. TheFly reported on May 8 that Baird reduced its price target on DH to $1.10 from $1.30 in a revised outlook, while a Neutral rating was maintained. […]
Analysts Have Made A Financial Statement On Definitive Healthcare Corp.'s (NASDAQ:DH) First-Quarter Report
Definitive Healthcare Corp. ( NASDAQ:DH ) shareholders are probably feeling a little disappointed, since its shares...
Definitive Healthcare Q1 Earnings Call Highlights
Definitive Healthcare (NASDAQ:DH) reported first-quarter fiscal 2026 results that management said came in “at or above the high end” of guidance on both revenue and profitability, while reiterating that the company remains in a transition period as it works to return to consistent top-line growth.
Definitive Healthcare Corp. Q1 2026 Earnings Call Summary
Moby summary of Definitive Healthcare Corp.'s Q1 2026 earnings call